Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) saw a significant increase in short interest during the month of May. As of May 29th, there was short interest totaling 11,366 shares, an increase of ∞ from the May 14th total of 0 shares. Based on an average daily trading volume, of 40,703 shares, the short-interest ratio is currently 0.3 days.
Fortress Biotech Price Performance
Fortress Biotech stock traded up $0.24 during midday trading on Monday, reaching $20.95. 27,279 shares of the stock traded hands, compared to its average volume of 24,733. The stock’s fifty day moving average is $15.83 and its 200-day moving average is $12.84. Fortress Biotech has a 12 month low of $6.27 and a 12 month high of $21.43.
Fortress Biotech Company Profile
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
Featured Stories
- Five stocks we like better than Fortress Biotech
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
